Mohamed Meshref

meshref mohamed, "A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer", World Conference on Lung Cancer, Netherlands, pp. Journal of Thoracic Oncology , vol 6 , No 6 , Supplement 6, 2011. a_randomized_phase_ii_study_comparing_maintnance.docx

meshref mohamed, A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer, , 2010. gem_nav.pdf

meshref mohamed, Comparative study on the effect of preoperative chemotherapy as recommended in the SIOP protocols versus the standard upfront surgical resection in cases of stage I, II and resectable stage III as recommended by the NWSG on the surgical outcome, rate of i, , 2014. wilms_tumor_paper_vs2.pdf

meshref mohamed, Smoking and Prognostic Factors in an Observational Setting in Patients with Advanced Non-Small Cell Lung Carcinoma, , 2011. smoking_and_prognostic_factors.pdf

meshref mohamed, Barriers and Challenges to Global Clinical Cancer Research, , 2014. theoncologist.alphamedpress.org_content_19_1_61.full_.pdf

meshref mohamed, A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/ without taxanes, , 2012. gem_cis.pdf

, Effect of different doses of prophylactic cranial irradiation in childhood lymphoblastic leukemia on CNS relapse, late cognitive decline and learning disabilities, , 2013. effect_of_different_doses_of_prophylactic_cranial_irradiation_in_childhood_lymphoblastic_lymphoma_on_cns_relapse.pdf

, Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial, , 2011. eur_journal_cardiothorathic_surgery.pdf

Li, C. - T., M. Marek, S. Z. Guclu, Y. Kim, M. Meshref, S. Qin, Z. Kadziola, K. Krejcy, and S. Altug, Smoking and Prognostic Factors in an Observational Setting in Patients with Advanced Non-Small Cell Lung Carcinoma, .

Mohamed Meshref

Professor of Clinical Oncology , Faculty of Medicine